Late on Mon­day, Abi­vax re­leased new tri­al da­ta on its ul­cer­a­tive col­i­tis can­di­date, show­ing that can­cer cas­es in a Phase 3 tri­al were with­in the...

Uni­cy­cive Ther­a­peu­tics’ chron­ic kid­ney dis­ease drug was re­ject­ed by the FDA for a sec­ond time over per­sis­tent is­sues at a third-par­ty con­tract man­u­fac­tur­er.

The com­pa­ny’s...

Plus news about Deer­field, In­flaRx, Prax­is, Nu­vec­tis, Pyx­is On­col­o­gy, Vista­gen, Ar­cutis Bio­ther­a­peu­tics and Nx­era.

🔎 FDA to de­cide on fu­ture of Sarep­ta ex­on-skip­ping drugs by...

A con­gres­sion­al com­mit­tee has opened an in­quiry in­to Bris­tol My­ers Squibb and Pfiz­er's use of clin­i­cal tri­al sites in Chi­na, in­clud­ing fa­cil­i­ties that the com­mit­tee's...